Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

High-throughput sequencing-based investigation of viruses in human cancers by multi-enrichment approach.

Mollerup S, Asplund M, Friis-Nielsen J, Kjartansdóttir KR, Fridholm H, Hansen TA, Herrera JAR, Barnes CJ, Jensen RH, Richter SR, Nielsen IB, Pietroni C, Alquezar-Planas DE, Rey-Iglesia A, Olsen PVS, De Meyts ER, Groth-Pedersen L, von Buchwald C, Jensen DH, Gniadecki R, Høgdall E, Langhoff JL, Pete I, Vereczkey I, Baranyai Z, Dybkaer K, Johnsen HE, Steiniche T, Hokland P, Rosenberg J, Baandrup U, Sicheritz-Pontén T, Willerslev E, Brunak S, Lund O, Mourier T, Vinner L, Izarzugaza JMG, Nielsen LP, Hansen AJ.

J Infect Dis. 2019 Jun 28. pii: jiz318. doi: 10.1093/infdis/jiz318. [Epub ahead of print]

PMID:
31253993
2.

La distinction entre le mélanome malin et d’autres lésions à l’aide de la dermoscopie.

Gniadecki R, Mourad A.

Can Fam Physician. 2019 Jun;65(6):e261-e263. French. No abstract available.

PMID:
31189639
Free Article
3.

Differentiating malignant melanoma from other lesions using dermoscopy.

Gniadecki R, Mourad A.

Can Fam Physician. 2019 Jun;65(6):412-414. No abstract available.

4.

Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing.

Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Salopek T, Wong GK, Gniadecki R.

Blood Adv. 2019 Apr 9;3(7):1175-1184. doi: 10.1182/bloodadvances.2018027482.

5.

Oral and Intraincisional Antibiotic Prophylaxis in Mohs Surgery: A Systematic Review and Meta-analysis.

Mourad A, Gniadecki R, Taher M.

Dermatol Surg. 2019 Feb 18. doi: 10.1097/DSS.0000000000001838. [Epub ahead of print] No abstract available.

PMID:
30883482
6.

Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis.

Mourad A, Gniadecki R.

J Rheumatol. 2019 Mar 1. pii: jrheum.180797. doi: 10.3899/jrheum.180797. [Epub ahead of print]

PMID:
30824641
7.

Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma.

Hamrouni A, Fogh H, Zak Z, Ødum N, Gniadecki R.

Clin Cancer Res. 2019 May 15;25(10):3104-3114. doi: 10.1158/1078-0432.CCR-18-4099. Epub 2019 Feb 26.

PMID:
30808775
8.

Macular cutaneous amyloidosis treated with methyl aminolevulinate and daylight photodynamic therapy: A case report.

Huang CM, Lam L, Gniadecki R.

SAGE Open Med Case Rep. 2019 Feb 15;7:2050313X19829617. doi: 10.1177/2050313X19829617. eCollection 2019.

9.

Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis.

Mourad A, Straube S, Armijo-Olivo S, Gniadecki R.

Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17738. [Epub ahead of print] Review.

PMID:
30729500
10.

Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis.

Lund T, Sand C, Gniadecki R, Thomsen SF.

Dermatol Ther. 2019 May;32(3):e12846. doi: 10.1111/dth.12846. Epub 2019 Feb 22. No abstract available.

PMID:
30697879
11.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis.

Dhadwal G, Albrecht L, Gniadecki R, Poulin Y, Yeung J, Hong CH, Gooderham MJ.

J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):21S-29S. doi: 10.1177/1203475418805721.

PMID:
30439301
12.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis.

Hong CH, Gooderham MJ, Albrecht L, Bissonnette R, Dhadwal G, Gniadecki R, Grewal P, Kirchhof MG, Landells I, Lansang P, Lynde CW, Papp KA, Poulin Y, Sussman G, Turchin I, Wiseman M, Yeung J.

J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):30S-35S. doi: 10.1177/1203475418803625.

PMID:
30439300
13.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document.

Gooderham MJ, Hong CH, Albrecht L, Bissonnette R, Dhadwal G, Gniadecki R, Grewal P, Kirchhof MG, Landells I, Lansang P, Lynde CW, Papp KA, Poulin Y, Sussman G, Turchin I, Wiseman M, Yeung J.

J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):3S-5S. doi: 10.1177/1203475418803627.

PMID:
30439298
14.

Prescribing Home Narrowband UVB Phototherapy: A Review of Current Approaches.

Hum M, Kalia S, Gniadecki R.

J Cutan Med Surg. 2019 Jan/Feb;23(1):91-96. doi: 10.1177/1203475418800947. Epub 2018 Sep 15.

PMID:
30221998
15.

Single-cell heterogeneity in Sézary syndrome.

Buus TB, Willerslev-Olsen A, Fredholm S, Blümel E, Nastasi C, Gluud M, Hu T, Lindahl LM, Iversen L, Fogh H, Gniadecki R, Litvinov IV, Persson JL, Bonefeld CM, Geisler C, Christensen JP, Krejsgaard T, Litman T, Woetmann A, Ødum N.

Blood Adv. 2018 Aug 28;2(16):2115-2126. doi: 10.1182/bloodadvances.2018022608.

16.

CCR4-targeted therapy in cutaneous T-cell lymphoma.

Gniadecki R.

Lancet Oncol. 2018 Sep;19(9):1140-1141. doi: 10.1016/S1470-2045(18)30449-2. Epub 2018 Aug 9. No abstract available.

PMID:
30100377
17.

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study.

Zouboulis CC, Okun MM, Prens EP, Gniadecki R, Foley PA, Lynde C, Weisman J, Gu Y, Williams DA, Jemec GBE.

J Am Acad Dermatol. 2019 Jan;80(1):60-69.e2. doi: 10.1016/j.jaad.2018.05.040. Epub 2018 Jun 1.

PMID:
29860040
18.

Psoriasis and risk of myocardial infarction before and during an era with biological therapy: a population-based follow-up study.

Leisner MZ, Lindorff Riis J, Gniadecki R, Iversen L, Olsen M.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2185-2190. doi: 10.1111/jdv.15021. Epub 2018 Jul 17.

PMID:
29719939
19.

Risk of skin cancer in patients with HIV: A Danish nationwide cohort study.

Omland SH, Ahlström MG, Gerstoft J, Pedersen G, Mohey R, Pedersen C, Kronborg G, Larsen CS, Kvinesdal B, Gniadecki R, Obel N, Omland LH.

J Am Acad Dermatol. 2018 Oct;79(4):689-695. doi: 10.1016/j.jaad.2018.03.024. Epub 2018 Mar 26.

PMID:
29588249
20.

Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis.

Gniadecki R, Leonardi CL, Gordon KB, Gu Y, Geng Z, Nader A, Teixeira HD.

J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1297-1304. doi: 10.1111/jdv.14926. Epub 2018 Jul 19.

PMID:
29524255
21.

Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis.

Loft ND, Skov L, Rasmussen MK, Gniadecki R, Dam TN, Brandslund I, Hoffmann HJ, Andersen MR, Dessau RB, Bergmann AC, Andersen NM, Abildtoft MK, Andersen PS, Hetland ML, Glintborg B, Bank S, Vogel U, Andersen V.

PLoS One. 2018 Feb 1;13(2):e0192010. doi: 10.1371/journal.pone.0192010. eCollection 2018.

22.

Correction to: Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.

Omland SH, Wettergren EE, Mollerup S, Asplund M, Mourier T, Hansen AJ, Gniadecki R.

BMC Cancer. 2018 Jan 30;18(1):111. doi: 10.1186/s12885-018-3987-4.

23.

Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.

Giberson M, Mourad A, Gniadecki R.

Dermatology. 2017;233(4):320-325. doi: 10.1159/000484203. Epub 2017 Nov 24. Review.

24.

Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.

Egeberg A, Ottosen MB, Gniadecki R, Broesby-Olsen S, Dam TN, Bryld LE, Rasmussen MK, Skov L.

Br J Dermatol. 2018 Feb;178(2):509-519. doi: 10.1111/bjd.16102. Epub 2018 Jan 9.

PMID:
29094341
25.

Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.

Omland SH, Wettergren EE, Mollerup S, Asplund M, Mourier T, Hansen AJ, Gniadecki R.

BMC Cancer. 2017 Oct 7;17(1):675. doi: 10.1186/s12885-017-3663-0. Erratum in: BMC Cancer. 2018 Jan 30;18(1):111.

26.

Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study.

Schwensen JF, Clemmensen A, Sand C, Gniadecki R, Skov L, Zachariae C, Iversen L, Rasmussen M, Thomsen SF.

Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12550. Epub 2017 Sep 14.

PMID:
28906051
27.

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.

Mangold AR, Thompson AK, Davis MD, Saulite I, Cozzio A, Guenova E, Hodak E, Amitay-Laish I, Pujol RM, Pittelkow MR, Gniadecki R.

J Am Acad Dermatol. 2017 Oct;77(4):719-727. doi: 10.1016/j.jaad.2017.05.036. Epub 2017 Jul 11.

PMID:
28709694
28.

Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis.

Loft ND, Skov L, Iversen L, Gniadecki R, Dam TN, Brandslund I, Hoffmann HJ, Andersen MR, Dessau RB, Bergmann AC, Andersen NM, Andersen PS, Bank S, Vogel U, Andersen V.

Pharmacogenomics J. 2018 May 22;18(3):494-500. doi: 10.1038/tpj.2017.31. Epub 2017 Jul 11.

PMID:
28696418
29.

[Mohs surgery for basal cell carcinoma].

Glud M, Omland SH, Paoli J, Gniadecki R.

Ugeskr Laeger. 2017 Feb 6;179(6). pii: V07160501. Review. Danish.

PMID:
28397683
30.

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R.

Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Review.

31.

Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis - nationwide results from the DERMBIO registry.

Egeberg A, Iversen L, Gniadecki R, Hvid L, Dam TN, Bryld LE, Skov L.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1183-1187. doi: 10.1111/jdv.14200. Epub 2017 Mar 29.

PMID:
28273375
32.

Psoralen with ultraviolet A-induced apoptosis of cutaneous lymphoma cell lines is augmented by type I interferons via the JAK1-STAT1 pathway.

Liszewski W, Naym DG, Biskup E, Gniadecki R.

Photodermatol Photoimmunol Photomed. 2017 May;33(3):164-171. doi: 10.1111/phpp.12302. Epub 2017 Apr 17.

PMID:
28196286
33.

A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis.

Omland SH, Habicht A, Damsbo P, Wilms J, Johansen B, Gniadecki R.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1161-1167. doi: 10.1111/jdv.14128. Epub 2017 Feb 17.

PMID:
28107559
34.

TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides.

Wooler G, Melchior L, Ralfkiaer E, Rahbek Gjerdrum LM, Gniadecki R.

Front Med (Lausanne). 2016 Nov 11;3:51. eCollection 2016.

35.

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology.

Ahmed AR, Carrozzo M, Caux F, Cirillo N, Dmochowski M, Alonso AE, Gniadecki R, Hertl M, López-Zabalza MJ, Lotti R, Pincelli C, Pittelkow M, Schmidt E, Sinha AA, Sprecher E, Grando SA.

Exp Dermatol. 2016 Nov;25(11):839-846. doi: 10.1111/exd.13106. Review.

PMID:
27305362
36.

Small-molecule inhibitors of Ataxia Telangiectasia and Rad3 related kinase (ATR) sensitize lymphoma cells to UVA radiation.

Biskup E, Naym DG, Gniadecki R.

J Dermatol Sci. 2016 Dec;84(3):239-247. doi: 10.1016/j.jdermsci.2016.09.010. Epub 2016 Sep 16.

PMID:
27743911
37.

High diversity of the T-cell receptor repertoire of tumor-infiltrating lymphocytes in basal cell carcinoma.

Omland SH, Hamrouni A, Gniadecki R.

Exp Dermatol. 2017 May;26(5):454-456. doi: 10.1111/exd.13240. Epub 2017 Jan 19.

PMID:
27714856
38.

Ubiquitin-specific peptidase 2 as a potential link between microRNA-125b and psoriasis.

Wei T, Folkersen L, Biskup E, Xu N, Manfe V, Niazi O, Gniadecki R.

Br J Dermatol. 2017 Mar;176(3):723-731. doi: 10.1111/bjd.14916. Epub 2016 Dec 30.

PMID:
27479112
39.

Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.

Wei T, Biskup E, Gjerdrum LM, Niazi O, Ødum N, Gniadecki R.

Oncotarget. 2016 Jul 26;7(30):48391-48400. doi: 10.18632/oncotarget.10268.

40.

[Basal cell carcinoma surgery].

Glud M, Omland SH, Gniadecki R.

Ugeskr Laeger. 2016 May 16;178(20). pii: V07150603. Review. Danish.

PMID:
27189106
41.

Chemotherapeutic treatment is associated with Notch1 induction in cutaneous T-cell lymphoma.

Kamstrup MR, Biskup E, Manfè V, Savorani C, Liszewski W, Wirèn J, Specht L, Gniadecki R.

Leuk Lymphoma. 2017 Jan;58(1):171-178. Epub 2016 May 16.

PMID:
27181628
42.

Immunosuppressive Environment in Basal Cell Carcinoma: The Role of Regulatory T Cells.

Omland SH, Nielsen PS, Gjerdrum LM, Gniadecki R.

Acta Derm Venereol. 2016 Nov 2;96(7):917-921. doi: 10.2340/00015555-2440.

43.

Patient Adherence to Biologic Agents in Psoriasis.

Hsu DY, Gniadecki R.

Dermatology. 2016;232(3):326-33. doi: 10.1159/000444581. Epub 2016 Apr 20.

44.

Pigmentary Markers in Danes--Associations with Quantitative Skin Colour, Nevi Count, Familial Atypical Multiple-Mole, and Melanoma Syndrome.

Johansen P, Andersen JD, Madsen LN, Ullum H, Glud M, Børsting C, Gniadecki R, Morling N.

PLoS One. 2016 Mar 3;11(3):e0150381. doi: 10.1371/journal.pone.0150381. eCollection 2016.

45.

STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.

Vieyra-Garcia PA, Wei T, Naym DG, Fredholm S, Fink-Puches R, Cerroni L, Odum N, O'Malley JT, Gniadecki R, Wolf P.

Clin Cancer Res. 2016 Jul 1;22(13):3328-39. doi: 10.1158/1078-0432.CCR-15-1784. Epub 2016 Feb 5.

46.

Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.

Willerslev-Olsen A, Krejsgaard T, Lindahl LM, Litvinov IV, Fredholm S, Petersen DL, Nastasi C, Gniadecki R, Mongan NP, Sasseville D, Wasik MA, Bonefeld CM, Geisler C, Woetmann A, Iversen L, Kilian M, Koralov SB, Odum N.

Blood. 2016 Mar 10;127(10):1287-96. doi: 10.1182/blood-2015-08-662353. Epub 2016 Jan 5.

47.

Next-generation antipsoriatic drugs: small molecules join.

Gniadecki R.

Br J Dermatol. 2015 Dec;173(6):1355-6. doi: 10.1111/bjd.14249. No abstract available.

PMID:
26708535
48.

[Severe atopic dermatitis caused by rare immunodeficiency in childhood].

Wolsk HM, Marquart HV, Laub B, Gniadecki R, Nysom K, Ifversen M.

Ugeskr Laeger. 2015 Dec 14;177(51):V06150498. Danish.

PMID:
26692033
49.

Favourable results of Mohs micrographic surgery for basal cell carcinoma.

Gniadecki R, Glud M, Mortensen K, Bang B, Biskup E, Omland SH.

Dan Med J. 2015 Dec;62(12):A5171.

PMID:
26621396
50.

Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.

Gniadecki R, Bang B, Sand C.

Br J Dermatol. 2016 May;174(5):1145-6. doi: 10.1111/bjd.14270. Epub 2016 May 4. No abstract available.

PMID:
26522308

Supplemental Content

Loading ...
Support Center